Ebola Outbreak: Cure Could Have Been Ready Years Ago, Experts Say

Among the most promising experimental Ebola vaccines is a drug called ZMapp - and it could have been ready to treat patients long ago had it not sat in a Pentagon drug testing agency for two years waiting for a contract, Bloomberg Businessweek has found. ZMapp, an antibody "cocktail" created by California-based Mapp Biopharmaceutical, has shown to be 100 percent effective in protecting monkeys from Ebola if administered to the animals within 24 hours of exposure.